¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)The Liver Week 2020 Virtual Confernence Day 2 : 2020-08-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)The Liver Week 2020 Virtual Confernence Day 2 : 2020-08-14
±³À°ÀÏÀÚ : 2020-08-14
±³À°Àå¼Ò : ¿Â¶óÀÎ Çмú´ëȸ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)The Liver Week 2020 Virtual Confernence Day 2      
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ 
¿¬¶ôó : 02-707-0091  
À̸ÞÀÏ : kasl@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 18 ½Ã°£ 10ºÐ        
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í Member-KRW 50,000/Resident, Trainee, Nurse, Army Doctor, Others-KRW 30,000Non-Member, Healthcare Professional-KRW 60,000      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 08:30~09:00 Hepatitis C Elimination Program in Taiwan: ¡°The Taiwan Hepatitis C Policy Guideline 2018 - 2025¡±  Chien-Jen Chen(Former Vice President of Taiwan, Academia Sinica, Taiwan) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:00~09:20 HCV Elimination in Taiwan: What and How We Have Achieved the Beginning till Today  Jia-Horng Kao(National Taiwan Univ., Taiwan) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:00~09:40 HCV Elimination in Japan: The Japanese Policy and Outcome  Tatsuya Kanto(National Center for Global Health and Medicine, Japan) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:40~10:00 National Policies on Hepatitis C in Korea  Hyung-Min Lee(Korea Centers for Disease Control & Prevention) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:00~10:20 Current Status and Suggestions for Hepatitis C Control in Korea  Do Young Kim(Yonsei Univ.) 
Åä·Ð 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:20~10:50 Panel Discussion  () 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 08:30~08:50 Hippo Pathway Regulation of Liver Inflammation and Cancer  Yingzi Yang(Harvard Univ., USA) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 08:50~09:10 Complement C3, tRNA-derived Fragments Gly-tRFs, and Alcoholic Liver Disease  Songqing He(Guangxi Medical Univ., China) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:10~09:30 Autophagy and Cancer  Wen-Xing Ding(Univ. of Kensas, USA) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:30~09:50 Risk Factors for Alcohol-Related Hepatocellular Carcinoma  Makiko Taniai(Tokyo Women¡¯s Medical Univ., Japan) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:50~10:00 Catecholamine Signaling Pathway Protects Alcoholic Fatty Liver by Inducing Growth Differentiation Factor 15  Hee-Hoon Kim(KAIST) 
Åä·Ð 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:00~10:20 Round Table Discussions  () 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 08:30~08:50 Tranomic Signature of Nonalcoholic Fatty Liver Disease  Murim Choi(Seoul National Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 08:50~09:10 Immunologic Circuits of Hepatocellular Carcinoma  Su Jong Yu(Seoul National Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:10~09:30 Interactive Interface between Gut Microbiome and Immunome in Alcohol-Related Liver Disease  Bernd Schnabl(Univ. of California San Diego, USA) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:30~09:50 Novel Immunomodulating Pharmabiotics for Hepatocellular Carcinoma  Han Soo Park(GIST) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:50~10:10 Pathology of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Overlap Syndrome  Masayoshi Kage(Kurume Univ., Japan) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:10~10:30 Autoimmune Hepatitis: From Bench to Clinic  Xiong Ma(Shanghai Jiao Tong Univ., China) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:30~10:50 Primary Biliary Cholangitis: Unsolved Issues and New Treatment  Gideon M. Hirschfield(Univ. of Birmingham, UK) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:30~10:50 Prognostic Potential of LncRNAs for Alcoholic Liver Disease Patients  Suthat Liangpunsakul(Indiana Univ., USA) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:50~11:10 Predictors of Steroid Non-Response and New Approaches in Severe Alcoholic Hepatitis  Shiv Kumar Sarin(Institute of Liver and Biliary Science, India) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:10~11:30 Global and Regional Impacts of Alcoholism Use on Public Health  Dong Joon Kim(Hallym Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:30~11:50 Impact of Genetic Traits and Drinking Mode on Alcoholic Liver Disease in China  Jia Xiao(Fujian Normal Univ., China) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:50~12:10 TAPPY: Multi-Professional Care of Alcoholic Patients  Masahiro Kikuchi(Tokyo Medical Center, Japan) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:10~12:20 The Evolution of Liver Donor Liver Transplantation for Alcoholic Liver Cirrhosis in a High-Volume Center: The Eastern Perspective  Jeffrey Samuel Co(Kaohsiung Chang Memorial Hospital, Taiwan) 
Åä·Ð 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:20~12:40 Round Table Discussions  () 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:00~12:00 Plenary Presentation 2  Jin Mo YangYang Won Nah(The Catholic Univ. of KoreaUniv. of Ulsan) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:00~13:20 Locoregional Therapy  Yoon Jun Kim(Seoul National Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:20~13:40 Down-Staging Living Donor Liver Transplantation  Jae Geun Lee(Yonsei Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:40~14:00 Is There a Role for TKIs and Immune Checkpoint Inhibitors?  Thomas Yau(Univ. of Hong Kong, China) 
Åä·Ð 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:00~14:10 Discussion  () 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:00~13:20 Established and Potential Biomarkers of Hepatocellular Carcinoma with Focus on Recent Clinical Trials  Joong-Won Park(National Cancer Center Korea) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:20~13:40 Imaging Biomarkers in the Era of Precision Medicine  Gyongyi Szabo(Harvard Univ., USA) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:40~14:00 Pathologic Biomarkers that Indicate the Aggressiveness and Prognosis of Hepatocellular Carcinoma  Young Nyun Park(Yonsei Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:30~14:40 General Oral Presentation 2 (*K)  Young Oh KweonSang-Jae Park(Kyungpook National Univ.National Cancer Center Korea) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:10~14:30 Tumor Localization in Oncologic Surgery  Masaki Ueno(Wakayama Medical Univ., Japan) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:30~14:50 Anatomical Liver Resection  Dai Hoon Han(Yonsei Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:50~15:10 Donor Hepatectomy  Young Rock Choi(Seoul National Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:20~15:20 KASL Plenary Presentation  Seong Gyu Hwang(CHA Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:20~15:40 New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Infection  Il Han Song(Dankook Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:40~16:00 Non-Invasive Diagnosis and Biomarkers in Alcohol-Related Liver Disease  Suthat Liangpunsakul(Indiana Univ., USA) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:00~16:20 Quantitative Imaging Biomarker in the Assessment of Hepatic Fibrosis and Steatosis  Woo Kyoung Jeong(Sungkyunkwan Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:20~16:40 Clinical Application of Liquid Biopsy as a Prognostic Biomarker in Hepatocellular Carcinoma  Soo Young Park(Kyungpook National Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:30~15:50 Liver Transplantation for Patients with Severe Alcoholic Hepatitis: Inside Stories of Patient Selection and Pretransplant Management  Philippe Mathurin(Chu De Lille, France) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:50~16:10 Risk Stratification and Optimal Management for Liver Transplantation in Acute-on-Chronic Liver Failure  Dong Hyun Sinn(Sungkyunkwan Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:10~16:30 Risk Stratification and Optimal Management for Liver Transplantation in Acute Liver Failure  Young-dong Yu(Korea Univ.) 
±³À°½Ã°£ 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:30~16:50 How to Improve Post-Transplant Outcomes in Patients with High MELD Scores  Dong-Hwan Jung(Univ. of Ulsan) 
Åä·Ð 08¿ù 14ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:50~17:00 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)The Liver Week 2020 Virtual Confernence Day 2 : 2020-08-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ 2020 the 30th KGOG Symposium and Workshop : 2020-08-15
´ÙÀ½±Û ´ëÇѼÒÈ­±â±â´É¼ºÁúȯ¹×¿îµ¿ÇÐȸ APNM 2020 (1ÀÏÂ÷) : 2020-08-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 62 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 39 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 46 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 52 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 43 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 39 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 16 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 17 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 35 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 20 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 17 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 41 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 30 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 32 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 24 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷